$RKDA
Arcadia Biosciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022024557 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.000M $1.878M $2.376M
YoY Change -53.94% -20.96% 656.69%
Cost Of Revenue $552.0K $1.344M $1.693M
YoY Change -71.75% -20.61% 397.94%
Gross Profit $448.0K $534.0K $683.0K
YoY Change 106.45% -21.82% -2376.67%
Gross Profit Margin 44.8% 28.43% 28.75%
Selling, General & Admin $4.214M $4.835M $6.312M
YoY Change -22.02% -23.4% 47.06%
% of Gross Profit 940.63% 905.43% 924.16%
Research & Development $500.0K $255.0K $1.038M
YoY Change 1.01% -75.43% -41.09%
% of Gross Profit 111.61% 47.75% 151.98%
Depreciation & Amortization $86.00K $90.00K $304.0K
YoY Change -58.85% -70.39% 38.18%
% of Gross Profit 19.2% 16.85% 44.51%
Operating Expenses $4.714M $5.090M $11.09M
YoY Change 4.52% -54.1% 40.46%
Operating Profit -$4.266M -$4.580M -$8.713M
YoY Change -0.63% -47.43% 14.93%
Interest Expense $1.495M $1.975M $15.00K
YoY Change -65.62% 13066.67% -34.78%
% of Operating Profit
Other Income/Expense, Net $20.00K $43.00K -$7.000K
YoY Change -120.0% -714.29%
Pretax Income -$4.315M -$2.876M -$2.835M
YoY Change -54.85% 1.45% -60.41%
Income Tax $13.00K $1.000K $1.000K
% Of Pretax Income
Net Earnings -$4.244M -$2.867M -$2.175M
YoY Change -54.28% 31.82% -65.97%
Net Earnings / Revenue -424.4% -152.66% -91.54%
Basic Earnings Per Share -$0.12 -$0.10
Diluted Earnings Per Share -$6.30 -$0.12 -$98.07K
COMMON SHARES
Basic Shares Outstanding 24.64M 22.19M 22.17M
Diluted Shares Outstanding 24.55M 22.18M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.64M $22.72M $35.53M
YoY Change -28.03% -36.05% 248.29%
Cash & Equivalents $20.60M $22.70M $35.50M
Short-Term Investments $0.00
Other Short-Term Assets $896.0K $1.244M $1.408M
YoY Change -0.44% -11.65% 17.33%
Inventory $2.571M $3.342M $5.447M
Prepaid Expenses
Receivables $1.287M $2.726M $1.453M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.40M $30.03M $43.83M
YoY Change -28.23% -31.49% 106.86%
LONG-TERM ASSETS
Property, Plant & Equipment $704.0K $848.0K $2.634M
YoY Change -69.27% -67.81% -72.27%
Goodwill $1.648M
YoY Change
Intangibles $40.00K $373.0K $3.905M
YoY Change -91.74% -90.45%
Long-Term Investments
YoY Change
Other Assets $165.0K $165.0K $182.0K
YoY Change -8.33% -9.34% -92.69%
Total Long-Term Assets $3.524M $4.443M $15.39M
YoY Change -58.69% -71.14% 21.31%
TOTAL ASSETS
Total Short-Term Assets $25.40M $30.03M $43.83M
Total Long-Term Assets $3.524M $4.443M $15.39M
Total Assets $28.92M $34.47M $59.23M
YoY Change -34.15% -41.79% 74.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.929M $47.00K $51.00K
YoY Change 4476.56% -7.84% 70.0%
Accrued Expenses $1.010M $986.0K $1.134M
YoY Change -5.96% -13.05% 62.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $36.00K
YoY Change -100.0% -94.93%
Total Short-Term Liabilities $4.209M $4.051M $6.489M
YoY Change -16.49% -37.57% -22.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $78.00K
YoY Change -100.0% -96.94%
Other Long-Term Liabilities $2.000M $2.000M $2.140M
YoY Change -3.38% -6.54% -80.4%
Total Long-Term Liabilities $2.000M $2.000M $2.218M
YoY Change -3.38% -9.83% -83.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.209M $4.051M $6.489M
Total Long-Term Liabilities $2.000M $2.000M $2.218M
Total Liabilities $8.022M $9.455M $19.01M
YoY Change -36.94% -50.25% -15.91%
SHAREHOLDERS EQUITY
Retained Earnings -$257.9M -$253.6M -$217.2M
YoY Change 13.87% 16.76%
Common Stock $278.9M $278.7M $257.1M
YoY Change 8.27% 8.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.03M $25.07M $39.85M
YoY Change
Total Liabilities & Shareholders Equity $28.92M $34.47M $59.23M
YoY Change -34.15% -41.79% 74.82%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$4.244M -$2.867M -$2.175M
YoY Change -54.28% 31.82% -65.97%
Depreciation, Depletion And Amortization $86.00K $90.00K $304.0K
YoY Change -58.85% -70.39% 38.18%
Cash From Operating Activities -$2.356M -$3.371M -$8.268M
YoY Change -64.62% -59.23% 19.48%
INVESTING ACTIVITIES
Capital Expenditures $26.00K $0.00 -$206.0K
YoY Change -129.55% -100.0% -28.97%
Acquisitions
YoY Change
Other Investing Activities $307.0K $341.0K $2.000K
YoY Change 1605.56% 16950.0% -98.18%
Cash From Investing Activities $281.0K $341.0K -$204.0K
YoY Change -501.43% -267.16% 13.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.515M 21.00K
YoY Change -100.0% 21400.0% -99.09%
NET CHANGE
Cash From Operating Activities -2.356M -3.371M -8.268M
Cash From Investing Activities 281.0K 341.0K -204.0K
Cash From Financing Activities 0.000 4.515M 21.00K
Net Change In Cash -2.075M 1.485M -8.451M
YoY Change -69.68% -117.57% 76.06%
FREE CASH FLOW
Cash From Operating Activities -$2.356M -$3.371M -$8.268M
Capital Expenditures $26.00K $0.00 -$206.0K
Free Cash Flow -$2.382M -$3.371M -$8.062M
YoY Change -63.76% -58.19% 21.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001469443
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37383
dei Entity Registrant Name
EntityRegistrantName
Arcadia Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0571538
dei Entity Address Address Line1
EntityAddressAddressLine1
202 Cousteau Place
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
dei Entity Address City Or Town
EntityAddressCityOrTown
Davis
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95618
dei City Area Code
CityAreaCode
530
dei Local Phone Number
LocalPhoneNumber
756-7077
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
RKDA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24642960
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22719000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28685000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
76000
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2726000
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1370000
CY2022Q3 us-gaap Inventory Net
InventoryNet
3342000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4433000
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
254000
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
990000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
900000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
30031000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
35388000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
848000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2291000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2073000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3081000
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
984000
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2494000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
373000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
484000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
165000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
180000
CY2022Q3 us-gaap Assets
Assets
34474000
CY2021Q4 us-gaap Assets
Assets
43918000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2748000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3638000
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
47000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
64000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
986000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1074000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
270000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
264000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4051000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5040000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1269000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2220000
CY2022Q3 rkda Common Stock Warrant And Option Liabilities
CommonStockWarrantAndOptionLiabilities
2135000
CY2021Q4 rkda Common Stock Warrant And Option Liabilities
CommonStockWarrantAndOptionLiabilities
3392000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2070000
CY2022Q3 us-gaap Liabilities
Liabilities
9455000
CY2021Q4 us-gaap Liabilities
Liabilities
12722000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24642960
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24642960
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22184235
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22184235
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
65000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
63000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
278618000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
257515000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253615000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226485000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
25068000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31093000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-49000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
103000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25019000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31196000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34474000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43918000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1878000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2376000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8956000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4609000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1344000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2511000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8250000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4954000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
255000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1038000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1009000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3328000
CY2022Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2021Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1138000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2877000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25019000
CY2021Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
120000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
72000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
120000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-0
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-70000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-140000
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
24000
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1108000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
370000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1319000
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
CY2021Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
386000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-17000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4835000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6312000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13834000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16733000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
6458000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
11089000
us-gaap Costs And Expenses
CostsAndExpenses
21941000
us-gaap Costs And Expenses
CostsAndExpenses
26331000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4580000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8713000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12985000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21722000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
95000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
123000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10214000
CY2022Q3 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
1880000
CY2021Q3 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
4777000
rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
1880000
rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
4601000
CY2022Q3 rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
0
CY2021Q3 rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
1123000
rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
0
rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
1123000
CY2022Q3 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
314000
CY2021Q3 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
0
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
314000
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
769000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-2876000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-2835000
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-11283000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-6576000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2877000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-2836000
us-gaap Profit Loss
ProfitLoss
-11284000
us-gaap Profit Loss
ProfitLoss
-6577000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-661000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-152000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1199000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2867000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2175000
us-gaap Net Income Loss
NetIncomeLoss
-11132000
us-gaap Net Income Loss
NetIncomeLoss
-5378000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24552543
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24552543
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22177423
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22177423
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22984816
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22984816
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20976105
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20976105
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-0
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-24000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2867000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2187000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11132000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5402000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31196000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
260000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-4610000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30242000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
323000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-3797000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26768000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
314000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28552000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
21000
CY2021Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
750000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
325000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1681000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45703000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-5422000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42678000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354000
CY2021Q3 rkda Stock Issued During Period Value Related To Exercise Of Services And Performance Warrants
StockIssuedDuringPeriodValueRelatedToExerciseOfServicesAndPerformanceWarrants
22000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-2836000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40223000
us-gaap Profit Loss
ProfitLoss
-11284000
us-gaap Profit Loss
ProfitLoss
-6577000
rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
1880000
rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
4601000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-70000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-140000
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
314000
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
769000
us-gaap Depreciation
Depreciation
354000
us-gaap Depreciation
Depreciation
737000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
686000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
914000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
72000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
120000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
386000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-17000
us-gaap Share Based Compensation
ShareBasedCompensation
897000
us-gaap Share Based Compensation
ShareBasedCompensation
1035000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
32000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
10222000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
370000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1319000
us-gaap Inventory Write Down
InventoryWriteDown
1530000
us-gaap Inventory Write Down
InventoryWriteDown
1802000
rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
0
rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
1123000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1138000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
534000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1071000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2651000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
90000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
452000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-15000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
159000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-890000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
972000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-29000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-718000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-984000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11621000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19208000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
897000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
285000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
919000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4250000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
21845000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1136000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16678000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
22000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2032000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
7000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
39000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
750000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4519000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22014000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-0
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5966000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19483000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28685000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16043000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22719000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35526000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Interest Paid Net
InterestPaidNet
1000
us-gaap Interest Paid Net
InterestPaidNet
25000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Stock Issued1
StockIssued1
2053000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
114000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1662000
rkda Proceeds From Sale Of Equity Method Investments In Accounts And Other Receivable
ProceedsFromSaleOfEquityMethodInvestmentsInAccountsAndOtherReceivable
854000
rkda Proceeds From Sale Of Equity Method Investments In Accounts And Other Receivable
ProceedsFromSaleOfEquityMethodInvestmentsInAccountsAndOtherReceivable
0
rkda Entity Place Of Incorporation
EntityPlaceOfIncorporation
Arizona
rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-152000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-661000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1200000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253600000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22700000
us-gaap Profit Loss
ProfitLoss
-11300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11600000
CY2021 us-gaap Profit Loss
ProfitLoss
-16100000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25900000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22700000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
15000
us-gaap Inventory Write Down
InventoryWriteDown
1500000
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
818000
us-gaap Inventory Write Down
InventoryWriteDown
1800000
CY2022Q3 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
1119000
CY2021Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
1851000
CY2022Q3 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
92000
CY2021Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
842000
CY2022Q3 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
3115000
CY2021Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
4234000
CY2022Q3 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
4326000
CY2021Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
6927000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5544000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7950000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4696000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5659000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
848000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2291000
us-gaap Depreciation
Depreciation
354000
us-gaap Depreciation
Depreciation
737000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
386000
CY2022Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
897000
CY2021Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0
CY2022Q3 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
254000
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
24000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
370000
CY2022Q3 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
20477000
CY2022Q3 rkda Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2022Q3 rkda Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2022Q3 rkda Debt And Equity Securities
DebtAndEquitySecurities
20477000
CY2021Q4 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
26842000
CY2021Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2021Q4 rkda Debt And Equity Securities
DebtAndEquitySecurities
26842000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20477000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26842000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
53000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
53000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
442000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1400000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
318000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
173000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
145000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
329000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
196000
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
546000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
173000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
373000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
617000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
484000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3300000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13000
us-gaap Lease Cost
LeaseCost
1008000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4000
CY2022Q3 rkda Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
18000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
145000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-152000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-661000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1200000
rkda Operating Lease Term Expiration Month And Year
OperatingLeaseTermExpirationMonthAndYear
2024-05
rkda Payments For Termination Fees
PaymentsForTerminationFees
47000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Some leases (the Davis and Dallas offices, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2073000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3081000
CY2022Q3 rkda Operating Lease Assets
OperatingLeaseAssets
2073000
CY2021Q4 rkda Operating Lease Assets
OperatingLeaseAssets
3081000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
986000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1074000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1269000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2220000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2255000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3294000
CY2022Q3 us-gaap Lease Cost
LeaseCost
165000
CY2021Q3 us-gaap Lease Cost
LeaseCost
360000
us-gaap Lease Cost
LeaseCost
543000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11510011
CY2021 rkda Stock Issued During Period Shares Related To Exercise Of Warrants
StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants
0
rkda Stock Issued During Period Shares Related To Exercise Of Warrants
StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13622517
rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1422195
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.28
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1320322
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.11
rkda Share Based Compensation Arrangement By Share Based Payment Award Grants Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsOutstandingIntrinsicValue
297000.00
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
266347
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
74436
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.04
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2401734
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.29
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2115782
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.55
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
873633
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.59
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
314000
us-gaap Share Based Compensation
ShareBasedCompensation
897000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
354000
us-gaap Share Based Compensation
ShareBasedCompensation
1000000.0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0004
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0002
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18710376
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13064920
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18710376
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13064920
CY2020Q2 rkda Number Of Lease Amendments
NumberOfLeaseAmendments
2
us-gaap Operating Lease Payments
OperatingLeasePayments
0
us-gaap Operating Lease Payments
OperatingLeasePayments
81000000

Files In Submission

Name View Source Status
0000950170-22-024557-index-headers.html Edgar Link pending
0000950170-22-024557-index.html Edgar Link pending
0000950170-22-024557.txt Edgar Link pending
0000950170-22-024557-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-20220930.htm Edgar Link pending
rkda-20220930.xsd Edgar Link pending
rkda-20220930_lab.xml Edgar Link unprocessable
rkda-20220930_htm.xml Edgar Link completed
rkda-ex31_1.htm Edgar Link pending
rkda-ex31_2.htm Edgar Link pending
rkda-ex32_1.htm Edgar Link pending
rkda-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rkda-20220930_pre.xml Edgar Link unprocessable
rkda-20220930_cal.xml Edgar Link unprocessable
rkda-20220930_def.xml Edgar Link unprocessable